Clinical Trial Update: Test of CD47-SIRPα Inhibitors on the Immune Microenvironment Colon Cancer

View source ↗

Summary

A clinical trial is recruiting to evaluate the effects of CD47-SIRPα inhibitors on the immune microenvironment in colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• CD47-SIRPα inhibitors

Snippet

Sponsor: Institut Paoli-Calmettes | Conditions: Cancer of the Colon | Status: RECRUITING